TG Therapeutics | TGTX - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
AbbVie USD 9.39B 4.16B 2026-03
Alaunos Therapeutics USD 354K 1.03M 2026-03
Amgen USD 12.04B 2.91B 2026-03
Ardelyx USD 31.21M 36.79M 2026-03
Arrowhead Research USD 201.64M 112.94M 2025-12
Bayer EUR 6.67B 774M 2025-12
Biogen USD 3.38B 374.2M 2026-03
Corcept Therapeutics USD 108.74M 11.76M 2026-03
Curis USD 10.14M 10.14M 2025-06
Gilead Sciences USD 7.56B 234M 2025-12
Infinity Pharmaceuticals USD 17.75M 7.99M 2023-06
J&J USD 21.69B 1.98B 2026-03
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Novartis USD 6.88B 4.56B 2026-03
Novavax USD 228.36M 12.27M 2026-03
PTC Therapeutics USD 833.99M 150.66M 2026-03
Puma Biotechnology USD 53.52M 1.14M 2025-09
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
TG Therapeutics USD 442.21M 242.7M 2026-03
Verastem USD 204.99M 67.28M 2025-12
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03